Largest health care pharmaceutical companies by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Pfizer leads the 61 health care pharmaceutical companies ranked by net assets, at PLN 347.1B, ahead of Johnson & Johnson (PLN 327.3B) and Sanofi (PLN 317.8B). Figures as of 19 Nov 2026, 09:15 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- PfizerPLN 347.1B
- Median
- PLN 3.5B
- Combined market value
- PLN 20.3T
- Countries
- 10
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | Net assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | PLN 347.1B | PLN 641.9B | PLN 112.62 | 1.44% down | 14% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | PLN 327.3B | PLN 2.63T | PLN 1,094.47 | 2.15% down | 38% up | ||
| 3 | SanofiSNY · Health Care | PLN 317.8B | PLN 454.1B | PLN 189.11 | 0.86% down | 4% down | ||
| 4 | Merck & CoMRK · Health Care | PLN 211.1B | PLN 1.36T | PLN 552.97 | 3.90% down | 51% up | ||
| 5 | Abbott LaboratoriesABT · Health Care | PLN 209.2B | PLN 726.2B | PLN 419.33 | 0.22% down | 17% down | ||
| 6 | AstraZenecaAZN · Health Care | PLN 195.3B | PLN 1.11T | PLN 717.44 | 1.93% down | 2% up | ||
| 7 | Takeda PharmaceuticalTAK · Health Care | PLN 186.7B | PLN 272.7B | PLN 85.37 | 1.71% down | 54% up | ||
| 8 | NovartisNVS · Health Care | PLN 185.1B | PLN 1.18T | PLN 622.93 | 2.46% down | 25% up | ||
| 9 | Regeneron PharmaceuticalsREGN · Health Care | PLN 125.4B | PLN 392.6B | PLN 3,794.84 | 1.28% down | 36% up | ||
| 10 | Novo NordiskNVO · Health Care | PLN 115.6B | PLN 697.5B | PLN 158.25 | 3.12% down | 17% down | ||
| 11 | Eli LillyLLY · Health Care | PLN 106.5B | PLN 4.94T | PLN 5,549.60 | 2.32% down | 35% up | ||
| 12 | GSKGSK · Health Care | PLN 87.2B | PLN 390.8B | PLN 194.97 | 1.34% down | 6% up | ||
| 13 | Vertex PharmaceuticalsVRTX · Health Care | PLN 74.9B | PLN 545.9B | PLN 2,153.02 | 0.42% up | 27% up | ||
| 14 | Bristol-Myers SquibbBMY · Health Care | PLN 74.1B | PLN 488.6B | PLN 239.04 | 2.92% down | 34% up | ||
| 15 | ViatrisVTRS · Health Care | PLN 59B | PLN 93.3B | PLN 81.39 | 0.83% down | 96% up | ||
| 16 | Royalty PharmaRPRX · Health Care | PLN 39B | PLN 158.5B | PLN 275.60 | 0.01% down | 78% up | ||
| 17 | Teva Pharmaceutical IndustriesTEVA · Health Care | PLN 31.7B | PLN 197.8B | PLN 169.49 | 0.92% down | 74% up | ||
| 18 | United TherapeuticsUTHR · Health Care | PLN 28.5B | PLN 98.7B | PLN 2,317.13 | 1.16% down | 23% up | ||
| 19 | Elanco Animal HealthELAN · Health Care | PLN 26.3B | PLN 53.6B | PLN 107.16 | 3.29% up | 20% up | ||
| 20 | BioMarin PharmaceuticalBMRN · Health Care | PLN 24.4B | PLN 47.8B | PLN 246.55 | 4.99% up | 11% up | ||
| 21 | GrifolsGRFS · Health Care | PLN 23.5B | PLN 23.1B | PLN 33.99 | 1.85% down | 1% up | ||
| 22 | GenmabGMAB · Health Care | PLN 23.5B | PLN 126.1B | PLN 204.57 | 1.91% down | 70% up | ||
| 23 | Roivant SciencesROIV · Health Care | PLN 18.2B | PLN 112.6B | PLN 155.44 | 0.05% up | 90% up | ||
| 24 | BeOne MedicinesONC · Health Care | PLN 17.5B | PLN 185B | PLN 1,619.83 | 2.34% down | 17% up | ||
| 25 | Jazz PharmaceuticalsJAZZ · Health Care | PLN 17.3B | PLN 63.8B | PLN 994.41 | 2.93% up | 37% up | ||
| 26 | Dr. Reddy's LaboratoriesRDY · Health Care | PLN 16.1B | PLN 50.1B | PLN 60.12 | 1.28% up | 5% up | ||
| 27 | ZoetisZTS · Health Care | PLN 13.4B | PLN 139.5B | PLN 343.43 | 2.50% up | 29% down | ||
| 28 | AlkermesALKS · Health Care | PLN 7.3B | PLN 31.6B | PLN 188.03 | 3.08% up | 58% up | ||
| 29 | Ligand PharmaceuticalsLGND · Health Care | PLN 4.1B | PLN 24B | PLN 1,198.86 | 1.67% up | 43% up | ||
| 30 | Legend BiotechLEGN · Health Care | PLN 4B | PLN 12.7B | PLN 65.22 | 0.87% up | 42% down | ||
| 31 | Praxis Precision MedicinesPRAX · Health Care | PLN 3.5B | PLN 34.2B | PLN 1,224.86 | 0.04% up | 61% up | ||
| 32 | Alnylam PharmaceuticalsALNY · Health Care | PLN 3.2B | PLN 80.3B | PLN 599.61 | 4.54% down | 66% down | ||
| 33 | Belite BioBLTE · Health Care | PLN 3.1B | PLN 25.5B | PLN 627.02 | 0.94% down | 31% up | ||
| 34 | InsmedINSM · Health Care | PLN 3B | PLN 105.5B | PLN 480.81 | 1.69% down | 40% down | ||
| 35 | Spyre TherapeuticsSYRE · Health Care | PLN 2.9B | PLN 38.7B | PLN 407.20 | 8.15% up | 286% up | ||
| 36 | Summit TherapeuticsSMMT · Health Care | PLN 2.6B | PLN 33.7B | PLN 42.14 | 1.59% down | 36% down | ||
| 37 | TG TherapeuticsTGTX · Health Care | PLN 2.6B | PLN 40.1B | PLN 265.37 | 5.44% up | 107% up | ||
| 38 | Corcept TherapeuticsCORT · Health Care | PLN 2.6B | PLN 29.8B | PLN 272.07 | 3.25% down | 8% down | ||
| 39 | Cogent BiosciencesCOGT · Health Care | PLN 2.6B | PLN 19.4B | PLN 111.61 | 0.14% down | 20% down | ||
| 40 | Protagonist TherapeuticsPTGX · Health Care | PLN 2.5B | PLN 33.3B | PLN 510.35 | 2.00% up | 46% up | ||
| 41 | Madrigal PharmaceuticalsMDGL · Health Care | PLN 2.4B | PLN 37.1B | PLN 1,597.67 | 5.67% down | 24% down | ||
| 42 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | PLN 2.3B | PLN 30B | PLN 381.48 | 0.06% down | 126% up | ||
| 43 | Edgewise TherapeuticsEWTX · Health Care | PLN 2.1B | PLN 18.2B | PLN 166.04 | 1.59% down | 88% up | ||
| 44 | ABIVAXABVX · Health Care | PLN 2B | PLN 29.5B | PLN 336.45 | 2.11% up | 27% down | ||
| 45 | Dianthus TherapeuticsDNTH · Health Care | PLN 2B | PLN 19B | PLN 337.05 | 3.45% down | 113% up | ||
| 46 | Ionis PharmaceuticalsIONS · Health Care | PLN 2B | PLN 18.3B | PLN 109.93 | 1.59% up | 64% down | ||
| 47 | Oruka TherapeuticsORKA · Health Care | PLN 1.9B | PLN 26.1B | PLN 384.25 | 0.60% down | 241% up | ||
| 48 | Arrowhead PharmaceuticalsARWR · Health Care | PLN 1.9B | PLN 24.5B | PLN 173.02 | 0.28% up | 10% up | ||
| 49 | Definium TherapeuticsDFTX · Health Care | PLN 1.3B | PLN 16B | PLN 116.87 | 0.88% down | 169% up | ||
| 50 | ErascaERAS · Health Care | PLN 1.3B | PLN 19.4B | PLN 55.23 | 0.94% down | 403% up | ||
| 51 | Mirum PharmaceuticalsMIRM · Health Care | PLN 1.3B | PLN 24.2B | PLN 371.20 | 0.59% up | 31% up | ||
| 52 | Rhythm PharmaceuticalsRYTM · Health Care | PLN 558.1M | PLN 33.1B | PLN 477.76 | 2.08% up | 13% up | ||
| 53 | Travere TherapeuticsTVTX · Health Care | PLN 460.9M | PLN 19.4B | PLN 201.64 | 1.68% down | 44% up | ||
| 54 | Axsome TherapeuticsAXSM · Health Care | PLN 354.4M | PLN 28.3B | PLN 537.80 | 1.43% down | 7% down | ||
| 55 | Amneal PharmaceuticalsAMRX · Health Care | -PLN 284.1M | PLN 30.6B | PLN 87.81 | 3.60% up | 83% up | ||
| 56 | VeradermicsMANE · Health Care | -PLN 485.7M | PLN 21.1B | PLN 501.12 | 0.62% down | 233% up | ||
| 57 | Ascendis PharmaASND · Health Care | -PLN 725M | PLN 71.2B | PLN 1,084.96 | 0.32% down | 28% up | ||
| 58 | PTC TherapeuticsPTCT · Health Care | -PLN 824M | PLN 20.2B | PLN 241.73 | 0.22% down | 20% down | ||
| 59 | CytokineticsCYTK · Health Care | -PLN 2.6B | PLN 28.7B | PLN 205.97 | 0.64% down | 20% down | ||
| 60 | BridgeBio PharmaBBIO · Health Care | -PLN 8.4B | PLN 61B | PLN 313.09 | 1.58% up | 17% up | ||
| 61 | AbbVieABBV · Health Care | -PLN 13.1B | PLN 2.03T | PLN 1,147.89 | 2.33% down | 26% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0134 PLN).
Questions and answers
Which health care pharmaceutical companies rank first by net assets?
Pfizer (PLN 347.1B), Johnson & Johnson (PLN 327.3B) and Sanofi (PLN 317.8B) are the top three of the 61 health care pharmaceutical companies ranked by net assets as of 19 Nov 2026, 09:15 UTC.
How many health care pharmaceutical companies are in this ranking?
61 are ranked by net assets.
What are these health care pharmaceutical companies worth together?
The 61 health care pharmaceutical companies ranked by net assets have a combined market value of PLN 20.3T as of 19 Nov 2026, 09:15 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care pharmaceutical companies by net assets”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.